Cell therapies for Parkinson's disease: how far have we come?

TB Stoker, RA Barker - Regenerative Medicine, 2016 - Taylor & Francis
Over the past three decades, significant progress has been made in the development of
potential regenerative cell-based therapies for neurodegenerative disease, with most …
被引用次数：27 相关文章
[PDF] semanticscholar.org

[PDF][PDF] Cell therapies for Parkinson's disease: how far have we come?

TB Stoker, A Roger - Regen. Med, 2016 - pdfs.semanticscholar.org
Progress in the development of regenerative cell-based therapies for neurodegenerative
conditions has taken several decades, partly due to inherent technical challenges in …

Cell therapies for Parkinson's disease: how far have we come?

TB Stoker, RA Barker - 2016 - repository.cam.ac.uk
Over the past three decades, significant progress has been made in the development of
potential regenerative cell-based therapies for neurodegenerative disease, with most …

Cell therapies for Parkinson's disease: how far have we come?

TB Stoker, RA Barker - Regenerative Medicine, 2016 - europepmc.org
Over the past three decades, significant progress has been made in the development of
potential regenerative cell-based therapies for neurodegenerative disease, with most …
[HTML] nih.gov

[HTML][HTML] Cell therapies for Parkinson's disease: how far have we come?

TB Stoker, RA Barker - Regenerative Medicine, 2016 - ncbi.nlm.nih.gov
Over the past three decades, significant progress has been made in the development of
potential regenerative cell-based therapies for neurodegenerative disease, with most …

Cell therapies for Parkinson's disease: how far have we come?

TB Stoker, RA Barker - Regenerative medicine, 2016 - pubmed.ncbi.nlm.nih.gov
Over the past three decades, significant progress has been made in the development of
potential regenerative cell-based therapies for neurodegenerative disease, with most …